Top Markets
Coin of the day
Pharmigene, Inc. Pharmigene, Inc.

Pharmigene, Inc.

7595
株式のランク #31882
Pharmigene, Inc. operates globally, specializing in the creation, production,... Pharmigene, Inc. operates globally, specializing in the creation, production, and distribution of diagnostic testing solutions. Its offerings include molecular diagnostic tools specifically designed to detect adverse drug reactions, alongside DNA extraction products crucial for diverse applications such as gene expression analysis, clinical molecular diagnostics, human identity verification, forensic investigations, and biomedical research. The firm also provides an array of specialized services, including pharmacogenomics, drug allergy screening, and functional medicine assessments. Beyond its own products, Pharmigene distributes various genomics and genetics equipment and reagents. Complementing these, it offers a comprehensive suite of support solutions, encompassing expert consultation, training programs, analytical software, and technical assistance. Furthermore, the company extends its capabilities through Contract Development and Manufacturing Organization (CDMO) services. Pharmigene, founded in 1994, is headquartered in Taipei, Taiwan.
株価
$0.23372286
時価総額
$11.79M
変化(1日)
-0.14%
変化(1年)
-36.99%
TW
取引 Pharmigene, Inc. (7595)

カテゴリー

Pharmigene, Inc.(7595)の収益
Aug 2026 時点の収益 TTM: 0
Pharmigene, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Pharmigene, Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。